In a press release dated July 2nd, Chr. Hansen posted results for the third quarter of fiscal 2020 ending May 31st, 2020.  Revenue increased by four percent from the corresponding third quarter of fiscal 2019 to $349 million.  Net profit was higher by five percent to $78 million.  The company generated a gross margin of 54.9 percent and the return on invested capital was 35 percent. Guidance for fiscal 2020 was reconfirmed and the company indicated it will announce the results of an ongoing strategy review on August 25th. Chr. Hansen has an asset value of $2.5 billion and carries $1.0 billion in long-term debt. 

In commenting on results, Mauricio Graber, CEO stated, "our business demonstrated resilience during the first volatile month since the outbreak of COVID-19, thanks to our essential natural ingredient solutions for the food, nutritional and agricultural industries".  He added "Animal Health continues to perform strongly driven by dairy products. Human Health also delivered strong growth supported by consumers' interest in probiotics with indications for immune benefits".